Semanteon Capital Management LP Acquires Shares of 4,507 Axon Enterprise, Inc. (NASDAQ:AXON)

Semanteon Capital Management LP bought a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,507 shares of the biotechnology company’s stock, valued at approximately $1,164,000.

Several other hedge funds and other institutional investors also recently modified their holdings of AXON. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 184.3% in the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after purchasing an additional 451,350 shares in the last quarter. Vaughan Nelson Investment Management L.P. lifted its holdings in Axon Enterprise by 18.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after buying an additional 16,230 shares during the last quarter. BKM Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Axon Enterprise by 0.3% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock valued at $29,320,000 after purchasing an additional 495 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $39,907,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

AXON traded up $3.83 on Thursday, reaching $306.24. The company had a trading volume of 305,890 shares, compared to its average volume of 469,582. The company has a market capitalization of $23.11 billion, a P/E ratio of 133.15 and a beta of 0.93. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The company has a fifty day moving average of $302.78 and a 200-day moving average of $260.58. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. The company had revenue of $432.14 million during the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. As a group, equities research analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent research reports. Barclays raised their price target on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday. StockNews.com lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $312.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.